Template:SUIT text D011: Difference between revisions
From Bioblast
(Created page with "SUIT-005 O2 pfi D011 protocols provide information on the F-pathway, the combined FN pathway, and the convergence FNS |...") |
No edit summary |
||
Line 1: | Line 1: | ||
SUIT-005 O2 pfi D011 | SUIT-005 O2 pfi D011 protocol provides information on the [[Fatty_acid_oxidation_pathway_control_state|F-pathway]], the combined [[FN|FN]] pathway, and the convergence [[FNS |FNS]] pathways in the [[Oxidative phosphorylation|OXPHOS state]]. [[FNS |FNS]] comprises the most important pathways in many cell types and thus provides a physiologically relevant estimate of maximum [[OXPHOS-capacity| OXPHOS-]] and [[ET-capacity |ET-capacity]]. SUIT-005 can be extended with the CIV assay module. | ||
This protocol is linked to [[SUIT-002 O2 pfi D006]] - SUIT RP2, specifically for human skeletal muscle mitochondria. SUIT-005 O2 pfi D011 is harmonized with [[SUIT-004 O2 pfi D010]]. | This protocol is linked to [[SUIT-002 O2 pfi D006]] - SUIT RP2, specifically for human skeletal muscle mitochondria. SUIT-005 O2 pfi D011 is harmonized with [[SUIT-004 O2 pfi D010]]. | ||
The F-pathway has to be tested previously. | The F-pathway has to be tested previously. |
Revision as of 11:01, 31 July 2019
SUIT-005 O2 pfi D011 protocol provides information on the F-pathway, the combined FN pathway, and the convergence FNS pathways in the OXPHOS state. FNS comprises the most important pathways in many cell types and thus provides a physiologically relevant estimate of maximum OXPHOS- and ET-capacity. SUIT-005 can be extended with the CIV assay module. This protocol is linked to SUIT-002 O2 pfi D006 - SUIT RP2, specifically for human skeletal muscle mitochondria. SUIT-005 O2 pfi D011 is harmonized with SUIT-004 O2 pfi D010. The F-pathway has to be tested previously.